Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
16.01
+0.02 (0.13%)
At close: May 28, 2025, 4:00 PM
16.07
+0.06 (0.37%)
After-hours: May 28, 2025, 4:04 PM EDT
Enliven Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$37.25
Upside
+132.67%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Maintains $36 → $27 | Strong Buy | Maintains | $36 → $27 | +68.64% | May 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $39 → $40 | Strong Buy | Maintains | $39 → $40 | +149.84% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $37 → $39 | Strong Buy | Maintains | $37 → $39 | +143.60% | Mar 21, 2025 |
| BTIG | BTIG | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +162.34% | Dec 13, 2024 |
| Baird | Baird | Buy Maintains $32 → $40 | Buy | Maintains | $32 → $40 | +149.84% | Nov 15, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +124.86% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +131.11% | Oct 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +131.11% | Sep 9, 2024 |
| Baird | Baird | Buy Initiates $32 | Buy | Initiates | $32 | +99.88% | Jun 11, 2024 |
| Mizuho | Mizuho | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +112.37% | Apr 9, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +68.64% | Mar 29, 2023 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 3, 2023 |